Predictive value of gelsolin for the outcomes of preterm neonates: A pilot study

Pediatrics International

Volumn 56, Issue 6, 2014, Pages 856-859

  Kose, Mehmet ^a   Elmas, Tuba ^a   Gokahmetoglu, Selma ^a   Ozturk, Mehmet Adnan ^a   Ekinci, Duygu ^a   Elmali, Ferhan ^a   Halis, Hulya ^a   Bastug, Osman ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

gelsolin; neonatal outcomes; prematurity

Indexed keywords

C REACTIVE PROTEIN; GELSOLIN; SURFACTANT;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PREDICTIVE VALUE; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; BLOOD; INFANT, PREMATURE, DISEASES;

FEMALE; GELSOLIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS;

EID: 84919338741     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12391     Document Type: Article

References (18)

1. Lee WM, Galbraith RM,. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 1992; 326: 1335-1341.
2. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP,. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am. J. Physiol. Cell Physiol. 2007; 292: 1323-1330.
3. Bucki R, Kulakowska A, Byfield FJ, et al. Plasma gelsolin modulates cellular response to sphingosine 1- phosphate. Am. J. Physiol. Cell Physiol. 2010; 299: C1516-1523.
4. Chauhan V, Ji L, Chauhan A,. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease. Biogerontology 2008; 9: 381-389.
5. DiNubile MJ,. Plasma gelsolin levels in the diagnosis, prognosis, and treatment of lung complications of prematurity. Am. J. Respir. Crit. Care Med. 2012; 186: 1195-1196.
6. Christofidou-Solomidou M, Scherpereel A, Solomides CC, et al. Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 2002; 180: 91-104.
7. Guo XC, Luo BY, Li XF, Yang DG, Zheng XN, Zhang K,. Plasma gelsolin levels and 1-year mortality after first-ever ischemic stroke. J. Crit. Care 2011; 26: 608-612.
8. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB,. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One 2008; 3: e3712.
9. Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012; 129: 1019-1026.
10. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP,. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit. Care Med. 2007; 35: 849-855.
11. Wang H, Cheng B, Chen Q, et al. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit. Care 2008; 12: R106.
12. Cohen TS, Bucki R, Byfield FJ, et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine 2011; 54: 235-238.
13. Lind SE, Smith DB, Janmey PA, Stossel TP,. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am. Rev. Respir. Dis. 1988; 138: 429-434.
14. Maniatis NA, Harokopos V, Thanassopoulou A, et al. A critical role for gelsolin in ventilator-induced lung injury. Am. J. Respir. Cell Mol. Biol. 2009; 4: 426-432.
15. Oikonomou N, Thanasopoulou A, Tzouvelekis A, et al. Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis. Thorax 2009; 64: 467-475.
16. Pan JW, He LN, Xiao F, Shen J, Zhan RY,. Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage. Crit. Care 2013; 17: R149.
17. Zhao DQ, Wang K, Zhang HD, Li YJ,. Significant reduction of plasma gelsolin levels in patients with intracerebral hemorrhage. Clin. Chim. Acta 2013; 415: 202-206.
18. Christofidou-Solomidou M, Scherpereel A, Solomides CC, et al. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J. Investig. Med. 2002; 50: 54-60.